Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease.
BACKGROUND:Chagas disease is due to the parasite Trypanosoma cruzi, a protist disseminated by a Triatome vector. This disease is endemic to Latin America and considered by WHO as one of the 17 world's neglected diseases. In Europe and in North America, imported cases are also detected, due to m...
Saved in:
Main Authors: | Elodie Granjon (Author), Marie-Laure D (Author), Esber Saba (Author), Ester Sabino (Author), Lea Campos de Oliveira (Author), Maan Zrein (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections
by: Lola Marqué, et al.
Published: (2021) -
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections.
by: Lola Marqué, et al.
Published: (2021) -
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure.
by: Amanda Fortes Francisco, et al.
Published: (2022) -
Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.
by: Rodolfo Viotti, et al.
Published: (2011) -
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
by: Maan Zrein, et al.
Published: (2018)